Decision Resources Group (DRG) is a global information and technology services company providing value-added data and analytics analysis to the entirety of the global healthcare community. DRG stands alone in its ability to provide high touch and thoughtful approaches which positively influence outcomes and economies for its global client base.Get Connected
Innovative technology, proprietary data
DRG has strategically combined best-of-breed health care information technology and services offerings over the past decade to become the most uniquely positioned HCIT Services company in the marketplace today.
Working with the largest biopharmaceutical, medical technology, and managed care providers in the world, DRG aggregates, analyzes, and actively puts to work its data and analytics. This provides DRG’s clients with access into a proprietary and value-added services offering, focused on syndicated research, consulting and data mining for the entirety of the health care community. DRG provides clients with an ability to nimbly access and generate customized solutions to real time problems by working with global thought leaders and strategists across all verticals of the health care spectrum.
DRG is one of the fastest growing companies in the United States -$5.7 billion global healthcare information industry. Forty-eight of the top 50 global life sciences companies are DRG customers, and DRG has an overall customer retention rate of 95%.
With over 1,000 employees and 17 offices worldwide, DRG provides the pharmaceutical, biotech, medical device, financial services, and managed care industries with the analytics necessary to compete and thrive in an increasingly competitive marketplace.
The three market segments that DRG covers are worth approximately US$2.5 billion, leaving considerable room for DRG to continue to increase its revenues.
The recent acquisition of Healthcare Business Insights (HBI), a trusted provider of best practice research, training, and services to more than 1,400 hospitals across the U.S., will further enable DRG to help hospitals and health systems in sharing best practices and understanding how best to address today’s most critical issues.
In concert with DRG’s core strengths of KOL mapping, industry leading databases around IDN and Hospital Affiliation Structures, and a Market Leading ACO Database, biopharma commercial and market access teams are able to target resources to key physicians who drive product adoption.
100 District Avenue, Suite 213
Burlington, MA 01803
United States of America
9 Appold St
London, EC2 A2AP
3 Killiney Road, 06-09,
Winsland House I,
Tel +65 6909 5300
Fax +65 6909 5304
6 Talisman Business Centre